Berlin Translational Dialogue – RNA-Medicine: From RNA Discoveries to Future Therapies

Tuesday, 08 November 2016


9:30 - 10:00 arrival & morning coffee


Opening by Michiel Kolman (SVP Global Academic Relations, Elsevier, Amsterdam)

Greetings from the Falling Walls Foundation by Ernst T. Rietschel (Member of the Board of Trustees)

Welcome by the scientific organizers Markus Landthaler (BIMSB-Berlin) & Gunter Meister (Uni Regensburg)

10:15 - 12:15

morning session (Chair M. Landthaler)

Jörg Vogel,
Director IMIB, Uni Würzburg, DE
Understanding host-pathogen interactions through RNA

Mariola Fotin-Mleczek, CSO CureVac, Tübingen, DE
Next Generation RNA Vaccines

Maria Carmo-Fonseca, President of the Institute for Molecular Medicine; Lisbon, PT
Targeting non-coding RNAs in biomedical research

Frank Slack, Director Institute for RNA-Medicine, BIDMC Boston, US 
MicroRNA-based therapeutics in cancer

12:15 - 13:30 lunch break

13:30 - 15:00

afternoon session (Chair G. Meister)
Nils G. Walter,
 Director Center for RNA Biomedicine Uni Michigan, US
Single Molecule Systems Biology and Diagnostics to Conquer RNA-Based Disease

Katalin Karikó, VP BioNTech RNA Pharmaceuticals Mainz, DE
Messenger RNA for therapy

Emmanuelle Charpentier, Director MPI-IB, Berlin, DE
CRISPR-Cas9: an RNA-based transformative discovery for biotechnology and medicine

15:00 - 15:30 coffee break

15:30 - 17:00

Interactive panel discussion 
moderated by Markus Landthaler (MDC-BIMSB)

Best institutional practices and innovative funding schemes to accelerate RNA-based medicines
Panelists:  Frank Slack,  Emanuelle Charpentier, Mariola Fotin-Mleczek, Jörg Vogel


close & departure


Contact Details